Ovid Therapeutics Inc. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↑+38.4% +$6M
$-10M
Free Cash Flow↑+100.0% +$22K
$0
Investing Cash Flow↑+1630.5% +$5M
$5M
Financing Cash Flow
$75M
Capex↓-100.0% -$22K
$0
Stock-Based Comp↓-5.2% -$65K
$1M
D&A↓-89.4% -$143K
$17K
SBC Allocated Expense↓-5.2% -$65K
$1M
SBC Unrecognized Cost
$16M